|
HY-100383-100mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-25mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-5mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-50mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100443A-1mg
|
MedChemexpress LLC
|
trans-PX20606 [CAS 1268244-85-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100443A-2mg
|
MedChemexpress LLC
|
trans-PX20606 [CAS 1268244-85-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100443B-1mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100443B-2mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100494-10mg
|
MedChemexpress LLC
|
SH5-07 [CAS 1456632-41-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100494-100mg
|
MedChemexpress LLC
|
SH5-07 [CAS 1456632-41-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100494-5mg
|
MedChemexpress LLC
|
SH5-07 [CAS 1456632-41-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100494-50mg
|
MedChemexpress LLC
|
SH5-07 [CAS 1456632-41-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-100522-1mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100522-10mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100522-100mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100522-25mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100522-5mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100522-50mg
|
MedChemexpress LLC
|
FMK 9a [CAS 1955550-51-2]
|
|
Cancer-programmed cell death
|
|
|
HY-100877-1mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-10mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-100mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-25mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-5mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-50mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101027-10mg
|
MedChemexpress LLC
|
GSK 4027 [CAS 2079896-25-4]
|
|
Cancer-programmed cell death
|
|
